Dezima Pharma's Acquisition

Dezima Pharma was acquired by Amgen on September 16, 2015.

Dezima Pharma develops drugs to treat dyslipidemia, a major modifiable risk for cardiovascular disease. Dezima's objective is to develop compounds from pre-clinical development to meaningful proof of …

Articles about Dezima Pharma's Acquisition: